| Code | Description | Claims | Beneficiaries | Total Paid |
| 99345 |
Prolong home eval add 15m |
356 |
289 |
$70K |
| 96127 |
|
377 |
336 |
$10K |
| 99350 |
Prolong home eval add 15m |
35 |
32 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
187 |
181 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
199 |
192 |
$2K |
| 96161 |
|
19 |
19 |
$269.99 |
| 1160F |
|
476 |
429 |
$4.76 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
475 |
428 |
$4.75 |
| 1159F |
|
473 |
428 |
$4.73 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
297 |
267 |
$2.97 |
| 1126F |
|
171 |
158 |
$1.71 |
| 1125F |
|
104 |
93 |
$1.04 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
28 |
27 |
$0.28 |
| 99501 |
|
19 |
19 |
$0.19 |
| 3074F |
|
16 |
12 |
$0.16 |